You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Details for New Drug Application (NDA): 020747

✉ Email this page to a colleague

NDA 020747 describes ACTIQ, which is a drug marketed by Cephalon and is included in one NDA. It is available from one supplier. Additional details are available on the ACTIQ profile page.

The generic ingredient in ACTIQ is fentanyl citrate. There are thirty-one drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fentanyl citrate profile page.

Summary for 020747

Tradename:	ACTIQ
Applicant:	Cephalon
Ingredient:	fentanyl citrate
Patents:	0

Suppliers and Packaging for NDA: 020747

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ACTIQ	fentanyl citrate	TROCHE/LOZENGE;TRANSMUCOSAL	020747	NDA AUTHORIZED GENERIC	Teva Pharmaceuticals USA, Inc.	0093-7865	0093-7865-65	30 BLISTER PACK in 1 CARTON (0093-7865-65) / 1 LOZENGE in 1 BLISTER PACK (0093-7865-19)
ACTIQ	fentanyl citrate	TROCHE/LOZENGE;TRANSMUCOSAL	020747	NDA AUTHORIZED GENERIC	Teva Pharmaceuticals USA, Inc.	0093-7866	0093-7866-65	30 BLISTER PACK in 1 CARTON (0093-7866-65) / 1 LOZENGE in 1 BLISTER PACK (0093-7866-19)

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TROCHE/LOZENGE;TRANSMUCOSAL			Strength	EQ 0.2MG BASE
Approval Date:	Nov 4, 1998	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TROCHE/LOZENGE;TRANSMUCOSAL			Strength	EQ 0.4MG BASE
Approval Date:	Nov 4, 1998	TE:		RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TROCHE/LOZENGE;TRANSMUCOSAL			Strength	EQ 0.6MG BASE
Approval Date:	Nov 4, 1998	TE:		RLD:	Yes

Expired US Patents for NDA 020747

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cephalon	ACTIQ	fentanyl citrate	TROCHE/LOZENGE;TRANSMUCOSAL	020747-006	Nov 4, 1998	4,863,737	⤷ Get Started Free
Cephalon	ACTIQ	fentanyl citrate	TROCHE/LOZENGE;TRANSMUCOSAL	020747-003	Nov 4, 1998	4,671,953	⤷ Get Started Free
Cephalon	ACTIQ	fentanyl citrate	TROCHE/LOZENGE;TRANSMUCOSAL	020747-005	Nov 4, 1998	5,785,989	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.